Treatment of Dedifferentiated Liposarcoma in the Era of Immunotherapy
Targeted therapies and immunotherapy are showing great promise for improving treatment outcomes in liposarcoma patients.
Liposarcoma Updates from ASCO Annual Meeting
At our first ASCO 2025, new research and clinical trial updates offered hope for better treatments and brighter outcomes for people with liposarcoma.
Liposarcoma Featured – Updates From CTOS 2024
CTOS is an annual meeting that brings together physicians & healthcare professionals to discuss new developments, treatments and advancements in sarcoma.